Abstract:Objective To investigate the effects of mesenchymal stem cells (MSC) on the polarization of macrophages under myocardial hypoxia condition, and reveal the underlying the mechanisms for polarization. Methods The supernatant of cardiomyocytes cultured in oxygen and glucose deprivation (OGD) was added into the culture medium of M0 macrophages to simulate myocardial hypoxia. Then the macrophages were directly co-cultured with MSC. To determine the effect of MSC on the M2 polarization of macrophages, the biological markers of M1/M2 macrophages were detected by flow cytometry, western blot and RT-PCR, respectively. And the expression of MyD88 (myeloid differentiation factor 88) and its upstream factors TLR2 (Toll-like receptor 2) and TLR4 (Toll-like receptor 4) as well as the phosphorylation level of NF-κB (nuclear factor-kappa B) and MAPK (mitogen-activated protein kinase) signaling pathway were measured. Results Compared with the control group, flow cytometry showed that M1 polarization were successfully induced in M0 macrophages cultured under myocardial hypoxia condition (P<0.05). Co-cultured with MSC, M0 was promoted significantly to M2 polarization (P<0.05). After adding different concentrations of MyD88 inhibitor, the proportion of M2 macrophages gradually increased with the dosage of ST2825 (P<0.05) compared with the control group. RT-qPCR showed that compared with the control group, the M2 macrophage-associated inflammatory factors IL-10 and TGF-β1 levels were increased after co-cultured with MSC (P<0.05). Western blot showed that the expression of TLR 2/4 and MyD88 in macrophages was down-regulated after co-cultured with MSC, and the phosphorylation level of downstream factors including P65, IKKAα/β, JNK1/2, P38, ERK1/2, the markers of the downstream signaling pathway of TLR2/4- MyD88, were reduced. Conclusions MSC promote the M2 polarization from M0 macrophages under myocardial hypoxia condition. One of the main mechanisms might be that MSC down-regulate the expression of TLR2, TLR4 and MyD88 in macrophages, and inhibit TLR2/4-MyD88 signaling and its downstream NF-κB and MAPK pathways.